Speakers

Hemaal Dhar is the Global Product Manager at Genes2.Me Pvt Ltd, where she supports the product strategy, steers market development, and management of next-generation sequencing (NGS) product portfolio. She collaborates closely with internal stakeholders across research & development and commercial teams to refine product offerings and drive adoption, ensuring that the NGS solutions are effectively aligned with both clinical requirements and market demands. She is involved in planning, market analysis, and product positioning, ensuring that the company’s NGS platforms meet the requirements of clinicians and laboratories while advancing the application of precision oncology in real-world settings.

Before working with Genes2Me, Hemaal worked with reputed diagnostic service companies and hospital chains like the Apollo Health Group in India, where she successfully launched multiple B2B and D2C brands in the Mother & Child (Genomics) care, preventive wellness and oncology portfolio (NGS), contributing to the growth and market adoption of innovative healthcare solutions by the clinicians. By integrating product leadership, educational initiatives, and industry insight, Hemaal facilitates the adoption of complex genomic technologies to enhance clinical decision-making and patient outcomes.